Giselle A. Baquero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Giselle A. Baquero has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Pradeep Yadav
Division of Cardiovascular Medicine, Piedmont Hospital, Atlanta, GA
3 shared publications Deborah L. Wolbrette
Department of Cardiology, Penn State College of Medicine, Penn State Heart and Vascular Institute, Hershey, USA
2 shared publicationsGerald V. Naccarelli
Department of Cardiology, Penn State College of Medicine, Penn State Heart and Vascular Institute, Hershey, USA
2 shared publications- Ian C. Gilchrist
Geisel School of Medicine at Dartmouth, Section of Cardiovascular Medicine, Heart and Vascular Center, Dartmouth Hitchcock Medical Center, Hanover, NH (I.C.G.).
2 shared publications Javier E. Banchs
Department of Cardiology, Penn State College of Medicine, Penn State Heart and Vascular Institute, Hershey, USA
2 shared publicationsChristoph Brehm
1 shared publication
Latest Publications
- 9 December 2014
- Published by Springer Nature in Current Heart Failure Reports
- Vol. 12 (2) , 150-157
Tricuspid Valve Incompetence Following Implantation of Ventricular Leads
Most cardiovascular implantable electronic devices (CIEDs) require a ventricular lead to be placed across the tricuspid valve. Tricuspid regurgitation (TR) is an understudied clinical complication of right ventricular lead implantation and its clinical significance is unknown. We review the incidence, predictors, and current management of TR as a complication of ventricular lead implantation. Emerging technologies, including leadless pacing devices and subcutaneous systems, offer the benefit of little or none tricuspid valve disruption.
- 9 December 2014
- Published by Springer Nature in Current Heart Failure Reports
- Vol. 12 (2) , 150-157
Tricuspid Valve Incompetence Following Implantation of Ventricular Leads
Most cardiovascular implantable electronic devices (CIEDs) require a ventricular lead to be placed across the tricuspid valve. Tricuspid regurgitation (TR) is an understudied clinical complication of right ventricular lead implantation and its clinical significance is unknown. We review the incidence, predictors, and current management of TR as a complication of ventricular lead implantation. Emerging technologies, including leadless pacing devices and subcutaneous systems, offer the benefit of little or none tricuspid valve disruption.
- 1 February 2014
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 7 (2) , S59
CRT-727 Percutaneous Balloon Atrial Septostomy for Direct Left Heart Decompression in Patients on Extra Corporeal Membrane Oxygenation
- 1 February 2014
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 7 (2) , S59
CRT-727 Percutaneous Balloon Atrial Septostomy for Direct Left Heart Decompression in Patients on Extra Corporeal Membrane Oxygenation
- 1 February 2014
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 7 (2) , S26
CRT-160 Same Day Discharge After Elective Percutaneous Coronary Interventions: A Single Center Experience in Contrast to the National Average
- 1 February 2014
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 7 (2) , S26
CRT-160 Same Day Discharge After Elective Percutaneous Coronary Interventions: A Single Center Experience in Contrast to the National Average
- 11 September 2013
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 38 (3) , 197-202
Clinical significance of increased tricuspid valve incompetence following implantation of ventricular leads
Purpose Cardiac rhythm management devices (CRMD) require a ventricular lead to be placed across the tricuspid valve. Tricuspid regurgitation (TR) is an under-recognized clinical complication of lead implantation and its clinical significance is unknown. We studied the incidence of hospitalizations for congestive heart failure (CHF) exacerbation among patients with worsening TR after ventricular lead implantation. Methods We reviewed 148 patients (age 68 ± 15) that received a CRMD. TR and pulmonary artery systolic pressure (PASP) measured by Doppler echocardiography before and after CRMD implantation were analyzed. Hospitalizations for CHF exacerbation post-implantation were counted. Results Follow-up was 32 ± 14 months. Ninety-nine (67 %) patients had no change, 24 (16 %) slight, and 9 (6 %) significant increase in TR after CRMD implantation, while 13 (9 %) patients had slight and 3 (2 %) significant improvement. Patients with a significant increase in TR had higher incidence of hospitalizations (1.7 ± 0.5) compared to patients with slight (0.8 ± 1; p = 0.006) or no increase (0.5 ± 1; p = 0.0002) in TR. Patients with significant increase in TR had a greater change in PASP (25 mmHg; p = 0.002) after device implantation compared to those with a slight (10 mmHg; p = 0.002) or no increase (0.7 mmHg; p = 0.17). Conclusion Increased TR following CRMD implantation is relatively common (33 %) and correlated with subsequent risk of hospitalization for heart failure. A preventive strategy and close monitoring for development or worsening of CHF after CRMD implantation may help prevent hospital admissions.
- 11 September 2013
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 38 (3) , 197-202
Clinical significance of increased tricuspid valve incompetence following implantation of ventricular leads
Purpose Cardiac rhythm management devices (CRMD) require a ventricular lead to be placed across the tricuspid valve. Tricuspid regurgitation (TR) is an under-recognized clinical complication of lead implantation and its clinical significance is unknown. We studied the incidence of hospitalizations for congestive heart failure (CHF) exacerbation among patients with worsening TR after ventricular lead implantation. Methods We reviewed 148 patients (age 68 ± 15) that received a CRMD. TR and pulmonary artery systolic pressure (PASP) measured by Doppler echocardiography before and after CRMD implantation were analyzed. Hospitalizations for CHF exacerbation post-implantation were counted. Results Follow-up was 32 ± 14 months. Ninety-nine (67 %) patients had no change, 24 (16 %) slight, and 9 (6 %) significant increase in TR after CRMD implantation, while 13 (9 %) patients had slight and 3 (2 %) significant improvement. Patients with a significant increase in TR had higher incidence of hospitalizations (1.7 ± 0.5) compared to patients with slight (0.8 ± 1; p = 0.006) or no increase (0.5 ± 1; p = 0.0002) in TR. Patients with significant increase in TR had a greater change in PASP (25 mmHg; p = 0.002) after device implantation compared to those with a slight (10 mmHg; p = 0.002) or no increase (0.7 mmHg; p = 0.17). Conclusion Increased TR following CRMD implantation is relatively common (33 %) and correlated with subsequent risk of hospitalization for heart failure. A preventive strategy and close monitoring for development or worsening of CHF after CRMD implantation may help prevent hospital admissions.
- 1 January 2013
- Vol. 40 (3) , 331-8
Isolated left ventricular noncompaction causing stroke in a 30-year-old woman: case report and literature review.
Isolated left ventricular noncompaction is a rare form of cardiomyopathy characterized by prominent left ventricular trabeculations and intertrabecular recesses. The typical clinical manifestations are severe systolic and diastolic dysfunction, conduction abnormalities, and cardiac embolic events theorized to result from thrombus formation within the intertrabecular recesses. Evidence-based recommendations for preventing thromboembolic events in isolated left ventricular noncompaction have not been established. We report the case of a woman who, at 10 years of age, had been diagnosed with hypertrophic cardiomyopathy without systolic dysfunction. At age 30, she presented with left hemiparesis consequent to a large right-hemispheric ischemic stroke, and she was diagnosed with isolated left ventricular noncompaction. In addition to discussing the patient's case, we review the medical literature that pertains to isolated left ventricular noncompaction.
- 1 January 2013
- Vol. 40 (3) , 331-8
Isolated left ventricular noncompaction causing stroke in a 30-year-old woman: case report and literature review.
Isolated left ventricular noncompaction is a rare form of cardiomyopathy characterized by prominent left ventricular trabeculations and intertrabecular recesses. The typical clinical manifestations are severe systolic and diastolic dysfunction, conduction abnormalities, and cardiac embolic events theorized to result from thrombus formation within the intertrabecular recesses. Evidence-based recommendations for preventing thromboembolic events in isolated left ventricular noncompaction have not been established. We report the case of a woman who, at 10 years of age, had been diagnosed with hypertrophic cardiomyopathy without systolic dysfunction. At age 30, she presented with left hemiparesis consequent to a large right-hemispheric ischemic stroke, and she was diagnosed with isolated left ventricular noncompaction. In addition to discussing the patient's case, we review the medical literature that pertains to isolated left ventricular noncompaction.
- 16 April 2012
- Published by Wiley in Congestive Heart Failure
- Vol. 18 (6) , 337-341
Cardiogenic Shock as the Initial Presentation of Systemic Lupus Erythematosus: A Case Report and Review of the Literature
- 16 April 2012
- Published by Wiley in Congestive Heart Failure
- Vol. 18 (6) , 337-341
Cardiogenic Shock as the Initial Presentation of Systemic Lupus Erythematosus: A Case Report and Review of the Literature